Grindr agreed to acquire the HIV-prevention telehealth provider Freddie for $250 million, the company’s first major acquisition as it expands into the healthcare business. The cash-and-stock deal reflects Chief Executive George Arison’s ambitions to transform Grindr from a dating and hookup app into a broader platform for the gay community that also provides health and wellness, travel, and luxury experiences.
Grindr will buy Freddie’s parent company, Purpose Med, for $190 million in cash and $60 million worth of stock. Purpose Med might also receive up to an additional $70 million in cash tied to 2027 performance targets. The deal is expected to close in the fourth quarter.
Arison said the acquisition would help sell drugs like PrEP, a prophylactic drug to ward off HIV, at little to no cost to gay men on Grindr’s platform. Freddie started in Canada in 2020 before expanding to the U.S. in 2024. Grindr’s priority will be scaling Freddie’s presence in the U.S., with the company projecting an annual revenue opportunity of around $240 million based on a U.S. patient base of 50,000.
The acquisition will build on Grindr’s first major play in the healthcare space. Last year, Grindr launched a telehealth business called Woodwork that provides drugs including GLP-1s and erectile-dysfunction treatments. Woodwork and Freddie will be merged into a single Grindr Health user experience.
Source: Wall Street Journal US Business · Summarized by HeadlinesBriefing